(Reuters) – PTC Therapeutics said on Friday the European Commission will remove its inherited progressive muscle-wasting disorder treatment from the region after an advisory panel reaffirmed a negative opinion of the drug last year. (This story has been corrected to say that the negative opinion was given last year, not in January, and to add the dropped word ‘treatment,’ in paragraph 1)
(Reporting by Christy Santhosh in Bengaluru; Editing by Shailesh Kuber)
Comments